Moderna Newsroom

Evercore Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60

Futu NewsOct 28 20:31

UBS Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $108

Futu NewsOct 25 07:31

Moderna Is Maintained at Buy by UBS

Dow JonesOct 25 01:27

Moderna Analyst Ratings

BenzingaOct 25 01:19

Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $115

Futu NewsOct 24 19:31

TD Cowen Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60

Futu NewsOct 21 19:34

Moderna Analyst Ratings

BenzingaOct 18 00:38

Moderna Analyst Ratings

BenzingaOct 16 00:57

Jefferies Financial lowers Moderna's target price to $55.

Gelonghui FinanceOct 15 17:07

Redburn Atlantic Adjusts Moderna's Price Target to $73 From $102, Keeps Neutral Rating

MT NewswiresOct 9 20:14

Goldman Sachs Adjusts Price Target on Moderna to $130 From $139

MT NewswiresOct 4 19:53

Gritstone Downgraded by Jones, B. Riley Over Cancer Vaccine Data

Seeking AlphaOct 3 00:39

Evercore ISI Adjusts Price Target on Moderna to $120 From $105, Maintains In Line

MT NewswiresOct 2 21:59

Deutsche Bank Cuts Moderna Price Target to $75 From $80

MT NewswiresSep 21 03:03

RBC Capital Reiterates Sector Perform on Moderna, Maintains $75 Price Target

BenzingaSep 19 22:03

Moderna Analyst Ratings

BenzingaSep 19 22:03

RBC Capital Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $75

Futu NewsSep 19 19:31

Goldman Sachs Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $139

Futu NewsSep 16 22:32

Goldman Sachs Maintains Buy on Moderna, Lowers Price Target to $139

BenzingaSep 16 22:16

Moderna Is Maintained at Overweight by Barclays

Dow JonesSep 16 21:58